NUS — NU Skin Enterprises Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesBalancedSmall CapSuper Stock

Annual income statement for NU Skin Enterprises, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	2,582	2,696	2,226	1,969	1,732
Cost of Revenue
Gross Profit	1,924	2,020	1,595	1,357	1,182
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses	2,324	2,462	2,115	1,921	1,884
Operating Profit	258	234	111	48.3	-152
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	256	232	89	26.6	-175
Provision for Income Taxes
Net Income After Taxes	191	147	105	8.6	-147
Net Income Before Extraordinary Items
Net Income	191	147	105	8.6	-147
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	191	147	105	8.6	-147
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	3.63	3.5	2.7	0.43	-0.303
Dividends per Share